Showing 3,321 - 3,340 results of 9,062 for search 'significant ((((gap decrease) OR (((we decrease) OR (greatest decrease))))) OR (mean decrease))', query time: 0.39s Refine Results
  1. 3321

    Morphological Change of Hydrate Caused by Ostwald Ripening and Sintering by Zelin Xu (14002343)

    Published 2025
    “…Hydrate Ostwald ripening and sintering were observable several weeks after the onset of formation, leading to a decrease in the particle number. Simultaneously, the particle size increased significantly without alteration of the overall hydrate saturation. …”
  2. 3322

    Antibodies information. by Xin Zhang (35492)

    Published 2025
    “…On histology of rat spinal tissue, compared with SCI rats, the combined treatment significantly increased neuron counts and BDNF levels, and significantly reduced the percentage of TUNEL-positive cells (all P<0.0001). …”
  3. 3323

    Original data. by Kenji Sato (657309)

    Published 2024
    “…</p><p>Methods</p><p>We retrospectively reviewed 150 patients [mean (standard deviation, SD) = 81 (9) years] discharged from the convalescent rehabilitation and community-based integrated care wards undergoing tailored home-based rehabilitation for 6 months (provided by physical or occupational therapists: 1–2 sessions of 40–60 min each per week). …”
  4. 3324

    Home-based rehabilitation program. by Kenji Sato (657309)

    Published 2024
    “…</p><p>Methods</p><p>We retrospectively reviewed 150 patients [mean (standard deviation, SD) = 81 (9) years] discharged from the convalescent rehabilitation and community-based integrated care wards undergoing tailored home-based rehabilitation for 6 months (provided by physical or occupational therapists: 1–2 sessions of 40–60 min each per week). …”
  5. 3325

    Baseline characteristics of study participants. by Kenji Sato (657309)

    Published 2024
    “…</p><p>Methods</p><p>We retrospectively reviewed 150 patients [mean (standard deviation, SD) = 81 (9) years] discharged from the convalescent rehabilitation and community-based integrated care wards undergoing tailored home-based rehabilitation for 6 months (provided by physical or occupational therapists: 1–2 sessions of 40–60 min each per week). …”
  6. 3326
  7. 3327

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  8. 3328

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  9. 3329

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  10. 3330

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  11. 3331

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  12. 3332

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  13. 3333

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  14. 3334

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  15. 3335

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  16. 3336

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  17. 3337

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  18. 3338

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  19. 3339
  20. 3340